Teriparatide increases bone mineral density at the spine and hip.
Teriparatide is an injectable drug to treat severe osteoporosis, a condition where mineral loss causes the bones to become brittle and to fracture easily.
Not so dense?
X-ray via www.shutterstock.com.
Scientists have identified a small number of people whose skeletons are extraordinarily break resistant, offering hints on how to make the bones of ordinary people stronger.
Expanding the definitions of disease can cause a cascade of overtesting and overtreatment.
Fort George G. Meade Public Affairs Office/Flickr
The creation of new “pre-conditions” is turning millions of people into patients across the globe.
Do you still need to take that?
As people with chronic conditions age or as their health changes, they sometimes need less medication. So when, should a person's drugs be scaled down?
Biomedical science has made our lives immeasurably better, but it’s time to accept that too much medicine can be as harmful as too little.
By forgetting that medicine postpones death rather than saving lives, we persuade ourselves it might somehow keep extending our life and come to view death as a failure of medicine.
A new odourless and easily administered treatment could help strengthen bones and prevent osteoporosis. Scientists tested…
A handheld device for diagnosing the early signs of osteoporosis could be available for clinical use within five years. Unlike…
There’s conflicting evidence about both the efficacy and the safety of taking calcium supplements.
A clash between supporters and detractors of calcium supplements for better bone health is leading to conflicting headlines, leaving the public unsure about whom to believe. Osteoporosis is estimated to…
Up to 2,000 of our 21,000 genes could affect our bone strength, research has found. In an experiment with mice, researchers…
A number of genes are strongly linked to the presence of osteoporosis and bone fractures, according to a new international…
The first in-human testing of a wireless medication dispenser was a success, according to a study published in the latest…